1. 37P Synthetic tumour-infiltrating interleukin (IL)-12 for targeted and tolerable immunotherapy reduces metastasis in pancreatic cancer. (December 2022) Authors: Herpels, M.; Mansurov, A.; Ragulan, C.; Hussain, A.; Ishihara, J.; Sadanandam, A. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗